Pain in Women pp 143-153 | Cite as

Pelvic Floor Muscle Pain and Dysfunction

  • Sharon Silveira
  • Samantha J. Pulliam
Chapter

Abstract

The pelvic floor provides anatomic support and coordinates the essential functions of defecation, micturition, and reproduction. The nerves and muscles of the pelvic floor act as an integrated unit, and when a component is compromised, dysfunction and pain can result. One type of dysfunction is the development of hypertonic muscles. The increased tone can lead to multiple problems seen by physicians including bladder or bowel pain, elimination disorders, vaginismus, vulvodynia, as well as chronic pelvic pain.

References

  1. 1.
    Bharucha AE, Trabuco E. Functional and chronic anorectal and pelvic pain disorders. Gastroenterol Clin North Am. 2008;37:685–96. ix.PubMedCrossRefGoogle Scholar
  2. 2.
    Bradley CS, Kennedy CM, Nygaard IE. Pelvic floor symptoms and lifestyle factors in older women. J Womens Health (Larchmt). 2005;14:128–36.CrossRefGoogle Scholar
  3. 3.
    Brisinda G, Maria G, Bentivoglio AR, et al. Management of bladder, prostatic and pelvic floor disorders. Neurotox Res. 2006;9:161–72.PubMedCrossRefGoogle Scholar
  4. 4.
    Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol. 2004;172:1242–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Butrick CW. Pelvic floor hypertonic disorders: identification and management. Obstet Gynecol Clin North Am. 2009;36:707–22.PubMedCrossRefGoogle Scholar
  6. 6.
    Butrick CW, Sanford D, Hou Q, Mahnken JD. Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:1047–53.PubMedCrossRefGoogle Scholar
  7. 7.
    Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology. 2007;70:16–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Barber MD, Bremer RE, Thor KB, Dolber PC, Kuehl TJ, Coates KW. Innervation of the female levator ani muscles. Am J Obstet Gynecol. 2002;187:64–71.PubMedCrossRefGoogle Scholar
  9. 9.
    FitzGerald MP. Chronic pelvic pain. Curr Womens Health Rep. 2003;3:327–33.PubMedGoogle Scholar
  10. 10.
    Butrick CW. Pathophysiology of pelvic floor hypertonic disorders. Obstet Gynecol Clin North Am. 2009;36:699–705.PubMedCrossRefGoogle Scholar
  11. 11.
    Graven-Nielsen T, Mense S. The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin J Pain. 2001;17:2–10.PubMedCrossRefGoogle Scholar
  12. 12.
    Verne GN, Price DD. Irritable bowel syndrome as a common precipitant of central sensitization. Curr Rheumatol Rep. 2002;4:322–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Doggweiler-Wiygul R. Urologic myofascial pain syndromes. Curr Pain Headache Rep. 2004;8:445–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Dietz HP. Pelvic floor trauma following vaginal delivery. Curr Opin Obstet Gynecol. 2006;18:528–37.PubMedCrossRefGoogle Scholar
  15. 15.
    Quinn M. Injuries to the levator ani in unexplained, chronic pelvic pain. J Obstet Gynaecol. 2007;27:828–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Peters KM, Carrico DJ. Frequency, urgency, and pelvic pain: treating the pelvic floor versus the epithelium. Curr Urol Rep. 2006;7:450–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Fitzgerald MP, Thom DH, Wassel-Fyr C, et al. Childhood urinary symptoms predict adult overactive bladder symptoms. J Urol. 2006;175:989–93.PubMedCrossRefGoogle Scholar
  18. 18.
    Gutman RE, Ford DE, Quiroz LH, Shippey SH, Handa VL. Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol. 2008;199:683.e1–7.CrossRefGoogle Scholar
  19. 19.
    Reissing ED, Brown C, Lord MJ, Binik YM, Khalife S. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol. 2005;26:107–13.PubMedCrossRefGoogle Scholar
  20. 20.
    Butrick CW. Interstitial cystitis and chronic pelvic pain: new insights in neuropathology, diagnosis, and treatment. Clin Obstet Gynecol. 2003;46:811–23.PubMedCrossRefGoogle Scholar
  21. 21.
    Fletcher JG, Busse RF, Riederer SJ, et al. Magnetic resonance imaging of anatomic and dynamic defects of the pelvic floor in defecatory disorders. Am J Gastroenterol. 2003;98:399–411.PubMedCrossRefGoogle Scholar
  22. 22.
    Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain. 2001;93:7–14.PubMedCrossRefGoogle Scholar
  23. 23.
    Carter JE. Diagnosis and treatment of the causes of chronic pelvic pain. J Am Assoc Gynecol Laparosc. 1996;3:S5–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Novi JM, Jeronis S, Srinivas S, Srinivasan R, Morgan MA, Arya LA. Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case–control study. J Urol. 2005;174:937–40.PubMedCrossRefGoogle Scholar
  25. 25.
    Lacerda-Filho A, Lima MJ, Magalhaes MF, Paiva Rde A, Cunha-Melo JR. Chronic constipation – the role of clinical assessment and colorectal physiologic tests to obtain an etiologic diagnosis. Arq Gastroenterol. 2008;45:50–7.PubMedCrossRefGoogle Scholar
  26. 26.
    De Paepe H, Hoebeke P, Renson C, et al. Pelvic-floor therapy in girls with recurrent urinary tract infections and dysfunctional voiding. Br J Urol. 1998;81 Suppl 3:109–13.PubMedGoogle Scholar
  27. 27.
    Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 1992;49:205–19.PubMedCrossRefGoogle Scholar
  28. 28.
    Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85:S3–14.PubMedCrossRefGoogle Scholar
  29. 29.
    Sator-Katzenschlager SM, Scharbert G, Kress HG, et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr. 2005;117:761–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Oyama IA, Rejba A, Lukban JC, et al. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology. 2004;64:862–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol. 2001;166:2226–31.PubMedCrossRefGoogle Scholar
  32. 32.
    FitzGerald MP, Anderson RU, Potts J, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2009;182:570–80.PubMedCrossRefGoogle Scholar
  33. 33.
    FitzGerald MP, Kotarinos R. Rehabilitation of the short pelvic floor. II: treatment of the patient with the short pelvic floor. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:269–75. discussion 275.PubMedCrossRefGoogle Scholar
  34. 34.
    Markwell SJ. Physical therapy management of pelvi/perineal and perianal pain syndromes. World J Urol. 2001;19:194–9.PubMedCrossRefGoogle Scholar
  35. 35.
    FitzGerald MP, Kotarinos R. Rehabilitation of the short pelvic floor. I: background and patient evaluation. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:261–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Langford CF, Udvari Nagy S, Ghoniem GM. Levator ani trigger point injections: an underutilized treatment for chronic pelvic pain. Neurourol Urodyn. 2007;26:59–62.PubMedCrossRefGoogle Scholar
  37. 37.
    Aoki KR, Francis J, Jost WH. Potential antinociceptive mechanisms of botulinum toxin. Schmerz. 2006;20:381–2. 384–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol. 2004;44:46–50.PubMedCrossRefGoogle Scholar
  39. 39.
    Ghazizadeh S, Nikzad M. Botulinum toxin in the treatment of refractory vaginismus. Obstet Gynecol. 2004;104:922–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108:915–23.PubMedCrossRefGoogle Scholar
  41. 41.
    Peters KM. Neuromodulation for the treatment of refractory interstitial cystitis. Rev Urol. 2002;4 Suppl 1:S36–43.PubMedGoogle Scholar
  42. 42.
    Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodriguez LV. Short-term results of bilateral S2–S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:553–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Alo KM, Holsheimer J. New trends in neuromodulation for the management of neuropathic pain. Neurosurgery. 2002;50:690–703. discussion 703–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Sharon Silveira
    • 1
  • Samantha J. Pulliam
    • 2
  1. 1.Department of Obstetrics and GynecologyMassachusetts General HospitalBostonUSA
  2. 2.Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Vincent Obstetrics and GynecologyMassachusetts General HospitalBostonUSA

Personalised recommendations